152 related articles for article (PubMed ID: 36935068)
1. Comparing levonorgestrel intrauterine system with hysteroscopic niche resection in women with postmenstrual spotting related to a niche in the uterine cesarean scar: a randomized, open-label, controlled trial.
Zhang J; Zhu C; Yan L; Wang Y; Zhu Q; He C; He X; Ji S; Tian Y; Xie L; Liang Y; Xia W; Mol BW; Huirne JAF
Am J Obstet Gynecol; 2023 Jun; 228(6):712.e1-712.e16. PubMed ID: 36935068
[TBL] [Abstract][Full Text] [Related]
2. Comparing levonorgestrel intrauterine system versus hysteroscopic resection in patients with postmenstrual spotting related to a niche in the caesarean scar (MIHYS NICHE trial): protocol of a randomised controlled trial.
He C; He X; Liang Y; Sun T; Yan L; Zhu C; Zhao X; Xie L; Mol BW; Zhang J; Huirne JAF
BMJ Open; 2021 Aug; 11(8):e045770. PubMed ID: 34462279
[TBL] [Abstract][Full Text] [Related]
3. The effect of a hysteroscopic niche resection compared with Levonorgestrel-releasing intrauterine device on postmenstrual spotting in patients with a symptomatic niche in the uterine cesarean scar: A prospective cohort study.
He X; Yan L; He C; Zhu C; Mol BW; Zhang J; Huirne JAF
Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():66-73. PubMed ID: 34461384
[TBL] [Abstract][Full Text] [Related]
4. Hysteroscopic resection of a uterine caesarean scar defect (niche) in women with postmenstrual spotting: a randomised controlled trial.
Vervoort A; van der Voet LF; Hehenkamp W; Thurkow AL; van Kesteren P; Quartero H; Kuchenbecker W; Bongers M; Geomini P; de Vleeschouwer L; van Hooff M; van Vliet H; Veersema S; Renes WB; Oude Rengerink K; Zwolsman SE; Brölmann H; Mol B; Huirne J
BJOG; 2018 Feb; 125(3):326-334. PubMed ID: 28504857
[TBL] [Abstract][Full Text] [Related]
5. The HysNiche trial: hysteroscopic resection of uterine caesarean scar defect (niche) in patients with abnormal bleeding, a randomised controlled trial.
Vervoort AJ; Van der Voet LF; Witmer M; Thurkow AL; Radder CM; van Kesteren PJ; Quartero HW; Kuchenbecker WK; Bongers MY; Geomini PM; de Vleeschouwer LH; van Hooff MH; van Vliet HA; Veersema S; Renes WB; van Meurs HS; Bosmans J; Oude Rengerink K; Brölmann HA; Mol BW; Huirne JA
BMC Womens Health; 2015 Nov; 15():103. PubMed ID: 26563197
[TBL] [Abstract][Full Text] [Related]
6. The effect of laparoscopic resection of large niches in the uterine caesarean scar on symptoms, ultrasound findings and quality of life: a prospective cohort study.
Vervoort A; Vissers J; Hehenkamp W; Brölmann H; Huirne J
BJOG; 2018 Feb; 125(3):317-325. PubMed ID: 28703935
[TBL] [Abstract][Full Text] [Related]
7. Improvement of symptoms after hysteroscopic isthmoplasty in women with abnormal uterine bleeding and expected pregnancy: A prospective study.
Nguyen AD; Nguyen HTT; Duong GTT; Phan TTH; Do DT; Tran DA; Nguyen TK; Nguyen TB; Ville Y
J Gynecol Obstet Hum Reprod; 2022 Mar; 51(3):102326. PubMed ID: 35091125
[TBL] [Abstract][Full Text] [Related]
8. The effect of a combined indomethacin and levonorgestrel-releasing intrauterine system on short-term postplacement bleeding profile: a randomized proof-of-concept trial.
Fels LM; Costescu D; Vieira CS; Peipert JF; Lukkari-Lax E; Hofmann BM; Reinecke I; Klein S; Wiesinger K; Lindenthal B; Speer R
Am J Obstet Gynecol; 2023 Mar; 228(3):322.e1-322.e15. PubMed ID: 36424684
[TBL] [Abstract][Full Text] [Related]
9. Clinical Success Rate of Extensive Hysteroscopic Cesarean Scar Defect Excision and Correlation to Histologic Findings.
Shapira M; Mashiach R; Meller N; Watad H; Baron A; Bouaziz J; Cohen SB
J Minim Invasive Gynecol; 2020 Jan; 27(1):129-134. PubMed ID: 30858053
[TBL] [Abstract][Full Text] [Related]
10. Naproxen or estradiol for bleeding and spotting with the levonorgestrel intrauterine system: a randomized controlled trial.
Madden T; Proehl S; Allsworth JE; Secura GM; Peipert JF
Am J Obstet Gynecol; 2012 Feb; 206(2):129.e1-8. PubMed ID: 22055339
[TBL] [Abstract][Full Text] [Related]
11. Levonorgestrel-Releasing Intrauterine Device Use Can Be a Treatment Option in Symptomatic Patients with Isthmocele.
Ketenci Gencer F; Dincgez B; Yuksel S
Reprod Sci; 2022 Oct; 29(10):2977-2982. PubMed ID: 35610461
[TBL] [Abstract][Full Text] [Related]
12. Management of initial bleeding or spotting after levonorgestrel-releasing intrauterine system placement: a randomized controlled trial.
Sørdal T; Inki P; Draeby J; O'Flynn M; Schmelter T
Obstet Gynecol; 2013 May; 121(5):934-941. PubMed ID: 23635728
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound evaluation of the Cesarean scar: relation between a niche and postmenstrual spotting.
Bij de Vaate AJ; Brölmann HA; van der Voet LF; van der Slikke JW; Veersema S; Huirne JA
Ultrasound Obstet Gynecol; 2011 Jan; 37(1):93-9. PubMed ID: 21031351
[TBL] [Abstract][Full Text] [Related]
14. Hysteroscopic management of displaced levonorgestrel-releasing intrauterine system.
Kuzel D; Hrazdirova L; Kubinova K; Dundr P; Cibula D; Mara M
J Obstet Gynaecol Res; 2013 May; 39(5):1014-8. PubMed ID: 23496334
[TBL] [Abstract][Full Text] [Related]
15. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
[TBL] [Abstract][Full Text] [Related]
16. Menstrual bleeding and spotting with the Levonorgestrel Intrauterine System (52 mg) during the first-year after insertion: a systematic review and meta-analysis.
Maldonado LY; Sergison JE; Gao X; Hubacher D
Am J Obstet Gynecol; 2020 May; 222(5):451-468.e9. PubMed ID: 31589865
[TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness of transvaginal repair vs. hysteroscopic resection in patients with symptomatic uterine niche.
Xia W; Wang X; Wang Y; Tian Y; He C; Zhu C; Zhu Q; Huang H; Shi L; Zhang J
Front Surg; 2023; 10():1019237. PubMed ID: 36843994
[TBL] [Abstract][Full Text] [Related]
18. Channel-like 360° Isthmocele Treatment with a 16F Mini-Resectoscope: A Step-by-step Technique.
Casadio P; Gubbini G; Morra C; Franchini M; Paradisi R; Seracchioli R
J Minim Invasive Gynecol; 2019; 26(7):1229-1230. PubMed ID: 31059782
[TBL] [Abstract][Full Text] [Related]
19. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
Mittermeier T; Farrant C; Wise MR
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012658. PubMed ID: 32909630
[TBL] [Abstract][Full Text] [Related]
20. Levonorgestrel intrauterine system for the treatment of intermenstrual spotting in patients with previous cesarean delivery scar defect.
Ou YC; Chen YY; Lan KC; Tsai CC; Chu LC; Cheng LY
J Obstet Gynaecol Res; 2022 Jan; 48(1):155-160. PubMed ID: 34734462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
